Events

Videos

Podcasts

Articles

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Robert Dean, MD, staff physician, Cleveland Clinic, discusses challenges in the mantle cell lymphoma (MCL) paradigm.

Dr. Dean on Challenges in the MCL Paradigm

Differentiating BTK Inhibitor Mechanisms of Action in MCL 

Identifying Unmet Needs in Relapsed/Refractory MCL  

MCL: Differences in Trial Design Between BTK Inhibitors 

Personal Insight Into Ibrutinib Use in Mantle Cell Lymphoma 

Advice for Future Management of Mantle Cell Lymphoma

Non-BTKi Agents' Role in Mantle Cell Lymphoma

MCL: Novel BTK Inhibitor Combination Strategies

Considering Off-Label Use of Ibrutinib in MCL

Managing Adverse Events of Ibrutinib in Patients With MCL

MCL: Long-Term Safety/Efficacy Data With Ibrutinib

Ibrutinib in MCL: Changing the Treatment Landscape 

Selecting Therapy for Relapsed/Refractory MCL

Optimizing Therapeutic Approaches to MCL

Mantle Cell Lymphoma: An Overview of Therapy

Distinguishing MCL From Other Lymphomas 

Mantle Cell Lymphoma: Impact of Genetic Variants 

Understanding the Heterogeneity of Mantle Cell Lymphoma 

Within 6 months of receiving induction chemotherapy, consolidation treatment with autologous hematopoietic cell transplantation correlated with a significant improvement in progression-free survival in younger, fit patients with mantle cell lymphoma.

AHCT Consolidation Improves PFS in Younger Patients With Mantle Cell Lymphoma

Krish Patel, MD, discusses some of the most significant mantle cell lymphoma data presented during the 2018 ASH Annual Meeting and how the use of BTK inhibitors will evolve going forward.

BTK Inhibition Continues to Show Promise in Relapsed/Refractory MCL

The OncLive Mantle Cell Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on mantle cell lymphoma treatment.  This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, therapeutic advances, and ongoing research in mantle cell lymphoma.